We are live on
!
Find out more
GIM
Glenmede Investment Management Portfolio holdings
AUM
$20.7B
This Fund
S&P 500
This Quarter
Est. Return
+9.24%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$19.8B
AUM Growth
–
Cap. Flow
+$18.6B
Cap. Flow
% of AUM
94.03%
Top 10 Holdings %
Top 10 Hldgs %
24.76%
Holding
1,498
New
1,498
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$852M |
| 2 |
Microsoft
MSFT
|
+$699M |
| 3 |
Apple
AAPL
|
+$687M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$517M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$474M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.26% |
| 2 | Financials | 11.2% |
| 3 | Healthcare | 8.68% |
| 4 | Consumer Discretionary | 8.36% |
| 5 | Industrials | 6.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Jones Lang LaSalle
JLL
$16.7B
| $9.93M | 0.05% |
+38,819
| New | +$8.9M |
|
352
EOG Resources
EOG
$74.6B
| $9.92M | 0.05% |
+82,956
| New | +$9.48M |
|
353
CDW
CDW
$16.8B
| $9.87M | 0.05% |
+55,257
| New | +$9.39M |
|
354
CarMax
KMX
$8.2B
| $9.77M | 0.05% |
+145,377
| New | +$9.78M |
|
355
McKesson
MCK
$104B
| $9.74M | 0.05% |
+13,290
| New | +$9.38M |
|
356
Datadog
DDOG
$89.4B
| $9.61M | 0.05% |
+71,518
| New | +$7.92M |
|
357
Dow Inc
DOW
$22.2B
| $9.57M | 0.05% |
+361,456
| New | +$10.5M |
|
358
MPLX
MPLX
$60.6B
| $9.56M | 0.05% |
+185,574
| New | +$9.43M |
|
|
NVO
359
Novo Nordisk
NVO
$201B
| $9.52M | 0.05% |
+137,990
| New | +$9.39M |
|
360
iShares Russell 2000 Value ETF
IWN
$14.6B
| $9.48M | 0.05% |
+60,076
| New | +$8.95M |
|
361
Newmont
NEM
$126B
| $9.11M | 0.05% |
+156,431
| New | +$8.35M |
|
362
Target
TGT
$68.9B
| $9.05M | 0.05% |
+91,732
| New | +$8.81M |
|
363
Neogen
NEOG
$2.47B
| $9.05M | 0.05% |
+1,892,619
| New | +$10.9M |
|
364
Everest Group
EG
$14B
| $9M | 0.05% |
+26,486
| New | +$9.14M |
|
365
Expeditors International
EXPD
$23.4B
| $8.99M | 0.05% |
+78,675
| New | +$8.81M |
|
366
General Dynamics
GD
$106B
| $8.99M | 0.05% |
+30,816
| New | +$8.48M |
|
367
Halozyme
HALO
$11.5B
| $8.81M | 0.04% |
+169,291
| New | +$9.63M |
|
368
Woodward
WWD
$21.2B
| $8.77M | 0.04% |
+35,792
| New | +$7.32M |
|
369
AstraZeneca
AZN
$245B
| $8.74M | 0.04% |
+62,538
| New | +$8.76M |
|
370
Cardinal Health
CAH
$55.1B
| $8.53M | 0.04% |
+50,782
| New | +$7.54M |
|
371
Energizer
ENR
$1.51B
| $8.53M | 0.04% |
+423,072
| New | +$10.2M |
|
372
Wabtec
WAB
$49.9B
| $8.52M | 0.04% |
+40,721
| New | +$7.83M |
|
373
APA Corp
APA
$14B
| $8.52M | 0.04% |
+465,739
| New | +$8.08M |
|
374
Hilton Worldwide
HLT
$72.1B
| $8.49M | 0.04% |
+31,871
| New | +$7.59M |
|
375
FedEx
FDX
$76B
| $8.46M | 0.04% |
+37,226
| New | +$8.15M |
|
Similar funds
CSS
ECM
JFL
BAM
SF
WIM
AIM
SIG
Glenmede Investment Management's Q2 2025 Portfolio in Review
Q2 2025 is the first quarter with a 13F filing on record for Glenmede Investment Management, which disclosed 1,498 positions worth $19.8B. Its ten largest holdings account for 25% of the portfolio.
Its largest position is Vanguard S&P 500 ETF: 1,621,868 shares worth $921M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, followed by Financials and Healthcare.
- Glenmede Investment Management's largest Q2 2025 buy was Vanguard S&P 500 ETF: 1,621,868 shares worth $921M.
- Glenmede Investment Management's ten largest holdings make up 25% of its $19.8B portfolio in Q2 2025.
- Glenmede Investment Management disclosed 1,498 positions in Q2 2025, its first 13F filing on record.
Based on Glenmede Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.